Actionable news
0
All posts from Actionable news
Actionable news in TEVA: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES,

Why Undervalued Teva Pharmaceutical Industries Is a Screaming Buy Today

Shares of Teva Pharmaceutical Industries (TEVA - Get Report) are receiving a welcome bump today after a share price slump that's lasted since late April. The catalysts for the rise were better-than-expected earnings and an announcement about a favorable forecast in one sector of the drug market.

Teva has been suffering due to a prolonged deal to acquire a portfolio of assets from fellow drugmaker Allergan. The deal, worth $40.5 billion, has been held up by the U.S. Federal Trade Commission (FTC) despite receiving clearance from European regulators.

Last Friday, Teva took a hit of nearly 7% when it reported that the FTC was still reviewing its case and that the company would divest as much as $2 billion in assets ahead of the sale. However, there's no guarantee that the divestiture would appease the FTC enough to push the Allergan acquisition through.

Must Read: Teva Shares' Slump on Friday Was Temporary -- This Stock Is a Buy

However, today the Israel-based pharmaceuticals company...


More